Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Oliveira, Patrícia ^a,b   Carvalho, Joana ^a,b   Rocha, Sara ^a,b   Azevedo, Mafalda ^b   Reis, Inês ^b   Camilo, Vânia ^b   Sousa, Bárbara ^a,b   Valente, Sofia ^a,b   Paredes, Joana ^a,b,c   Almeida, Raquel ^a,b,c   Huntsman, David ^d   Oliveira, Carla ^a,b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; ID2 PROTEIN, HUMAN; ID3 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR PROTEIN; VISTA PROTEIN, HUMAN;

DNA METHYLATION; DOWN REGULATION; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; PATHOLOGY; PROMOTER REGION; STOMACH TUMOR; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

B7 ANTIGENS; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; INHIBITOR OF DIFFERENTIATION PROTEINS; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MICROENVIRONMENT;

EID: 84990946691     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34860     Document Type: Article

References (51)

1. Cunningham, F., et al. Ensembl 2015. Nucleic acids research 43, D662-D669, doi: 10.1093/nar/gku1010 (2015).
2. Aloia, L., Parisi, S., Fusco, L., Pastore, L. & Russo, T. Differentiation of embryonic stem cells 1 (Dies1) is a component of bone morphogenetic protein 4 (BMP4) signaling pathway required for proper differentiation of mouse embryonic stem cells. The Journal of biological chemistry 285, 7776-7783, doi: 10.1074/jbc.M109.077156 (2010).
3. Battista, M., et al. miR-125b regulates the early steps of ESC differentiation through dies1 in a TGF-independent manner. International journal of molecular sciences 14, 13482-13496, doi: 10.3390/ijms140713482 (2013).
4. Ren, G., Beech, C. & Smas, C. M. The immunoglobulin superfamily protein differentiation of embryonic stem cells 1 (dies1) has a regulatory role in preadipocyte to adipocyte conversion. Plos one 8, e65531, doi: 10.1371/journal.pone.0065531 (2013).
5. Wang, L., et al. Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity. Proceedings of the National Academy of Sciences of the United States of America 111, 14846-14851, doi: 10.1073/pnas.1407447111 (2014).
6. Le Mercier, I., et al. VISTA Regulates the Development of Protective Antitumor Immunity. Cancer research 74, 1933-1944, doi: 10.1158/0008-5472.CAN-13-1506 (2014).
7. Yoon, K. W., et al. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science 349, 1261669, doi: 10.1126/science.1261669 (2015).
8. Lee, J. M., Dedhar, S., Kalluri, R. & Thompson, E. W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. The Journal of cell biology 172, 973-981, doi: 10.1083/jcb.200601018 (2006).
9. Puisieux, A., Brabletz, T. & Caramel, J. Oncogenic roles of EMT-inducing transcription factors. Nature cell biology 16, 488-494, doi: 10.1038/ncb2976 (2014).
10. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. The Journal of clinical investigation 119, 1420-1428, doi: 10.1172/JCI39104 (2009).
11. Ye, X. & Weinberg, R. A. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends in cell biology 25, 675-686, doi: 10.1016/j.tcb.2015.07.012 (2015).
12. Wu, K. J. & Yang, M. H. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection. Bioscience reports 31, 449-455, doi: 10.1042/BSR20100114 (2011).
13. Mani, S. A., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715, doi: 10.1016/j.cell.2008.03.027 (2008).
14. Peinado, H., Portillo, F. & Cano, A. Transcriptional regulation of cadherins during development and carcinogenesis. The International journal of developmental biology 48, 365-375, doi: 10.1387/ijdb.041794hp (2004).
15. Khan, M. A., Chen, H. C., Zhang, D. & Fu, J. Twist: a molecular target in cancer therapeutics. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 34, 2497-2506, doi: 10.1007/s13277-013-1002-x (2013).
16. Sanchez-Tillo, E., et al. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cellular and molecular life sciences: CMLS 69, 3429-3456, doi: 10.1007/s00018-012-1122-2 (2012).
17. van Nes, J. G., et al. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients. Breast cancer research and treatment 133, 49-59, doi: 10.1007/s10549-011-1684-y (2012).
18. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867, doi: 10.1038/nature01322 (2002).
19. Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883-899, doi: 10.1016/j.cell.2010.01.025 (2010).
20. Fichtner-Feigl, S., Kesselring, R. & Strober, W. Chronic inflammation and the development of malignancy in the GI tract. Trends in immunology 36, 451-459, doi: 10.1016/j.it.2015.06.007 (2015).
21. Fox, J. G. & Wang, T. C. Inflammation, atrophy, and gastric cancer. The Journal of clinical investigation 117, 60-69, doi: 10.1172/ JCI30111 (2007).
22. Li, Q., Karam, S. M. & Gordon, J. I. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. The Journal of biological chemistry 271, 3671-3676 (1996).
23. Lu, W. D., Zuo, Y., Xu, Z. & Zhang, M. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. World journal of gastroenterology 21, 4564-4573, doi: 10.3748/wjg.v21.i15.4564 (2015).
24. Chen, J., et al. Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer. Journal of experimental & clinical cancer research: CR 33, 38, doi: 10.1186/1756-9966-33-38 (2014).
25. Huang, J., et al. EphA2 promotes epithelial-mesenchymal transition through the Wnt/beta-catenin pathway in gastric cancer cells. Oncogene 33, 2737-2747, doi: 10.1038/onc.2013.238 (2014).
26. Peng, Z., Wang, C. X., Fang, E. H., Wang, G. B. & Tong, Q. Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World journal of gastroenterology 20, 5403-5410, doi: 10.3748/wjg.v20.i18.5403 (2014).
27. Zhao, X., et al. Mobilization of epithelial mesenchymal transition genes distinguishes active from inactive lesional tissue in patients with ulcerative colitis. Human molecular genetics 24, 4615-4624, doi: 10.1093/hmg/ddv192 (2015).
28. Pinho, S. S., et al. Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions. PloS one 7, e33191, doi: 10.1371/journal.pone.0033191 (2012).
29. Takai, D. & Jones, P. A. The CpG island searcher: a new WWW resource. In silico biology 3, 235-240 (2003).
30. Pang, M. F., et al. TGF-beta1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Oncogene, doi: 10.1038/onc.2015.133 (2015).
31. Parisi, S., et al. A regulatory loop involving Dies1 and miR-125a controls BMP4 signaling in mouse embryonic stem cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 26, 3957-3968, doi: 10.1096/fj.12-211607 (2012).
32. Dweep, H. & Gretz, N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nature methods 12, 697, doi: 10.1038/ nmeth.3485 (2015).
33. Forbes, S. A., et al. COSMIC: exploring the worlds knowledge of somatic mutations in human cancer. Nucleic acids research 43, D805-D811, doi: 10.1093/nar/gku1075 (2015).
34. Parkinson, H., et al. ArrayExpress update-an archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic acids research 39, D1002-D1004, doi: 10.1093/nar/gkq1040 (2011).
35. Balabanova, S., et al. The neuroendocrine phenotype of gastric myofibroblasts and its loss with cancer progression. Carcinogenesis 35, 1798-1806, doi: 10.1093/carcin/bgu086 (2014).
36. Battula, V. L., et al. Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem cells 28, 1435-1445, doi: 10.1002/stem.467 (2010).
37. de Winter, J. P., Roelen, B. A., ten Dijke, P., van der Burg, B. & van den Eijnden-van Raaij, A. J. DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 14, 1891-1899, doi: 10.1038/sj.onc.1201017 (1997).
38. Pohl, M., et al. SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells. Anticancer Res. 30, 2603-2613, doi: 30/7/2603 (2010).
39. Kaiser, C., et al. Chemogenomic analysis identifies Macbecin II as a compound specific for SMAD4-negative colon cancer cells. Chem Biol Drug Des. 75, 360-368, doi: JPP949 10.1111/j.1747-0285.2010.00949.x (2010).
40. Gartner, F., David, L., Seruca, R., Machado, J. C. & Sobrinho-Simoes, M. Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice. Virchows Arch 428, 91-98 (1996).
41. Motoyama, T., Hojo, H. & Watanabe, H. Comparison of seven cell lines derived from human gastric carcinomas.Acta Pathol Jpn. 36, 65-83 (1986).
42. Huang, N., et al. MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/ Akt signaling. Oncotarget 6, 15222-15234, doi: 10.18632/oncotarget.3835 (2015).
43. Yang, Z., et al. Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression. Biochemical and biophysical research communications 358, 925-930, doi: 10.1016/j.bbrc.2007.05.023 (2007).
44. Yano, K., Imaeda, T. & Niimi, T. Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells. American journal of physiology. Gastrointestinal and liver physiology 294, G336-G343, doi: 10.1152/ajpgi.00328.2007 (2008).
45. Li, J., et al. Zipper-interacting protein kinase promotes epithelial-mesenchymal transition, invasion and metastasis through AKT and NF-kB signaling and is associated with metastasis and poor prognosis in gastric cancer patients. Oncotarget 6, 8323-8338, doi: 10.18632/oncotarget.3200 (2015).
46. Kang, H. C., et al. Beyond the GIST: mesenchymal tumors of the stomach. Radiographics: a review publication of the Radiological Society of North America, Inc. 33, 1673-1690, doi: 10.1148/rg.336135507 (2013).
47. Wang, L., et al. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. The Journal of experimental medicine 208, 577-592, doi: 10.1084/jem.20100619 (2011).
48. Lines, J. L., Sempere, L. F., Broughton, T., Wang, L. & Noelle, R. VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy. Cancer immunology research 2, 510-517, doi: 10.1158/2326-6066.CIR-14-0072 (2014).
49. Holmberg, C., et al. Release of TGFbetaig-h3 by gastric myofibroblasts slows tumor growth and is decreased with cancer progression. Carcinogenesis 33, 1553-1562, doi: 10.1093/carcin/bgs180 (2012).
50. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001).
51. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/ (2013).